Reported Oct 5, 2022 · Terminated
ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading…
Leading Pharma, LLC
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Leading Pharma, LLC · 3 Oak Rd · Fairfield, NJ · 07004-2903
Is this the product you have?
- ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA
- Manufactured byLeading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-167-01
- Lot codes and dates
Lot#: B14221Exp. Date 02/2023
- Amount recalled
- 960 bottles (100 capsules)
Where it was sold
- Nationwide
Why it was recalled
Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Leading Pharma, LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.